Advertisement
Correspondence| Volume 37, ISSUE 12, P895-896, June 15, 1995

Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease

DOI:https://doi.org/10.1016/0006-3223(95)00035-F
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease
Previous ArticleMaintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease
Next ArticleDoes vitamin E prevent tardive dyskinesia?
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Altman HJ
        • Normile HJ
        What is the nature of the role of the serotonergic nervous system in learning and memory: Prospects for the development of an effective treatment strategy for senile dementia.
        Neurobiol Aging. 1985; 9: 627-638
        • Bowen DM
        • Allen SJ
        • Benton JS
        • et al.
        Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy and Alzheimer's disease.
        J Neurochem. 1983; 41: 266-272
        • Cross AJ
        • Crow TJ
        • Ferrier IN
        • et al.
        Serotonin receptor changes in dementia of the Alzheimer type.
        J Neurochem. 1984; 53: 1574-1581
        • Khachaturian ZS
        Diagnosis of Alzheimer's disease.
        Arch Neurol. 1985; 42: 1097-1105
        • McKhann G
        • Drachman D
        • Folstein M
        • Katzman R
        • Price D
        • Stadlan EM
        Clinical diagnosis of Alzheimer's disease.
        Neurology. 1984; 34 (Report of the NINCDS-ADRDA Work Group): 939-944
        • Mirra SS
        • Heyman A
        • McKeel D
        • Sumi SM
        • Crain BJ
        • Brownlee LM
        • Vogel FS
        • Hughes JH
        • vanBelle G
        • Berl I
        The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease.
        Neurology. 1991; 41: 479-486
        • Palmer AM
        • Francis PT
        • Benton JS
        • et al.
        Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.
        J Neurochem. 1987; 48: 8-15
        • Palmer AM
        • Statman GC
        • Procter AW
        • et al.
        Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.
        Ann Neurol. 1988; 34: 616-620
        • Rosen WG
        • Mohs RC
        • Davis KL
        A new scale for Alzheimer's disease.
        Am J Psychiatry. 1984; 141: 1356-1364
        • Zubenko GS
        • Moosy J
        Major depression in primary dementia: clinical and neuropathological correlates.
        Arch Neurol. 1988; 45: 1182-1186
        • Zubenko GS
        • Moossy J
        • Kopp U
        Neurochemical correlates of major depression in primary dementia.
        Arch Neurol. 1990; 47: 209-214
        • Zubenko GS
        • Moosy J
        • Martinez AJ
        • et al.
        Neuropathological and neurochemical correlates of psychosis in primary dementia.
        Arch Neurol. 1991; 48: 619-623
        • Zweig RM
        • Ross CA
        • Hedreen JC
        • et al.
        The neuropathology of aminergic nuclei in Alzheimer's disease.
        Ann Neurol. 1988; 24: 233-242

      Article info

      Identification

      DOI: https://doi.org/10.1016/0006-3223(95)00035-F

      Copyright

      © 1995 Society of Biological Psychiatry. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX